Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2A | P28223 | 5/20 | 0.54 |
| ▸ | HTR2C | P28335 | 4/20 | 0.54 |
| ▸ | HTR1A | P08908 | 3/20 | 0.54 |
| ▸ | HTR2B | P41595 | 3/20 | 0.54 |
| ▸ | HTR1D | P28221 | 2/20 | 0.54 |
| ▸ | HTR1B | P28222 | 2/20 | 0.54 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.54 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.54 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.54 |
| ▸ | HTR1E | P28566 | 1/20 | 0.54 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.54 |
| ▸ | HTR7 | P34969 | 1/20 | 0.54 |
| ▸ | HTR6 | P50406 | 1/20 | 0.54 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.52 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.52 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.52 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.52 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.52 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25937517 | 0.88 | PTPRA (0.46) | HTR2AHTR2CHTR1AHTR2BHTR1D | |
| SCHEMBL25304139 | 0.87 | PTPRA (0.57) | HTR2AHTR2CHTR1AHTR2BHTR1D | |
| SCHEMBL25307935 | 0.87 | PTPRA (0.57) | HTR2AHTR2CHTR1AHTR2BHTR1D | |
| SCHEMBL25842172 | 0.85 | KDM4E (0.57) | HTR2AHTR2CHTR1AHTR2BSLC6A4 | |
| SCHEMBL29804890 | 0.83 | HTR2A (0.57) | HTR2AHTR2CHTR1AHTR2BHTR1D | |
| SCHEMBL25260689 | 0.83 | HTR2A (0.57) | HTR2AHTR2CHTR1AHTR2BHTR1D | |
| SCHEMBL26202498 | 0.82 | HTR2A (0.44) | HTR2AHTR2CHTR1AHTR2BHTR1D | |
| SCHEMBL25842178 | 0.81 | HTR2A (0.42) | HTR2AHTR2CHTR1AHTR2BHTR1D | |
| SCHEMBL16433255 | 0.81 | NPC1 (0.50) | HTR2AHTR2CHTR1AHTR2BHTR1D | |
| SCHEMBL31549198 | 0.79 | ALDH1A1 (0.48) | SLC6A2CYP2C9NFKB1NPSR1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230219888-A1 | PRENYLATED PSILOCYBIN DERIVATIVES AND METHODS OF USING | MAGICMED INDUSTRIES INC. (CA) | 2023-07-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230219888-A1 | PRENYLATED PSILOCYBIN DERIVATIVES AND METHODS OF USING | AANAT, ACAT2, PCYT1A | HTR2A 1566/4885HTR2C 1158/4885HTR1A 1419/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.